Sign in

CIK 0001393434

  • Large accelerated filer

OCULAR THERAPEUTIX, INC

Sign in to watch
Ticker
OCUL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 781-357-4000
Business address
14 CROSBY DRIVE, 3RD FLOOR, BEDFORD, MA, 01730
Former names
I-THERAPEUTIX INC
  1. 4 Planned sale Chief Scientific Officer sold 3,063 shares at $12.04 ($36,879)
  2. 4 Planned sale See Remarks sold 21,494 shares at $12.04 ($258,788)
  3. 4 Grant or award Chief Medical Officer acquired 40,363 shares (grant or award)
  4. 4 Gift See Remarks gave 250,361 shares (gift)
  5. 3 Insider Initial Statement of Ownership
  6. 3 Insider Initial Statement of Ownership
  7. 4 Derivatives Options or other derivatives
  8. 4 Grant or award Director acquired 14,000 shares (grant or award)
  9. 4 Grant or award Director acquired 14,000 shares (grant or award)
  10. 4 Grant or award Director acquired 14,000 shares (grant or award)
  11. 4 Grant or award Director acquired 14,000 shares (grant or award)
  12. 4 Grant or award Director acquired 14,000 shares (grant or award)
  13. 4 Grant or award Director acquired 14,000 shares (grant or award)
  14. 4 Planned sale Chief Medical Officer sold 13,861 shares at $8.05 ($111,581)
  15. 4 Planned sale Chief Strategy Officer sold 1,862 shares at $7.17 ($13,351)
  16. 4 Planned sale Chief Development Officer sold 2,974 shares at $7.17 ($21,324)
  17. 4 Planned sale Chief Scientific Officer sold 3,024 shares at $7.18 ($21,712)
  18. 4 Planned sale See Remarks sold 21,219 shares at $7.18 ($152,352)
  19. 4 Open-market buy Director bought 10,000 shares at $6.96 ($69,600)
  20. 4 Planned sale See Remarks sold 21,475 shares at $6.87 ($147,533)

Page 4 of 18 · 354 filings